Shares of Boston Scientific Corp. BSX advanced 1.30% to $52.80 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.04% to 4,167.87 and Dow Jones Industrial Average DJIA falling 0.14% to 34,051.70.

This was the stock's third consecutive day of gains.

The AstraZeneca PLC ADR AZN inched 0.38% higher to $73.50 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.11% to 12,212.60 and Dow Jones Industrial Average DJIA falling 0.14% to 34,051.70.

AstraZeneca PLC ADR closed $3.06 below its 52-week high ($76.56), which the company achieved on April 25th.

Shares of AFLAC Inc. AFL inched 0.73% higher to $70.36 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.04% to 4,167.87 and Dow Jones Industrial Average DJIA falling 0.14% to 34,051.70.

This was the stock's third consecutive day of gains.

Shares of AbbVie Inc. ABBV rallied 1.71% to $153.71 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.04% to 4,167.87 and Dow Jones Industrial Average DJIA falling 0.14% to 34,051.70.

This was the stock's second consecutive day of gains.

Shares of Abbott Laboratories ABT inched 0.58% higher to $111.11 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.04% to 4,167.87 and Dow Jones Industrial Average DJIA falling 0.14% to 34,051.70.

This was the stock's third consecutive day of gains.